CARLOS
CAMPS HERRERO
EMÉRITO/A UNIVERSIDAD
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (2)
2011
-
Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases
Journal of Thoracic Oncology, Vol. 6, Núm. 7, pp. 1260-1266
2004
-
Prospective randomised phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer
Clinical Lung Cancer, Vol. 6, Núm. 3, pp. 175-183